Document Detail


Reduced serum osteocalcin concentrations are associated with type 2 diabetes mellitus and the metabolic syndrome components in postmenopausal women: the crosstalk between bone and energy metabolism.
MedLine Citation:
PMID:  22752126     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
Although it has been shown that osteocalcin functions as a hormone in the regulation of glucose metabolism and fat mass, no population-based study to date has addressed serum osteocalcin levels in relation to energy metabolism concurrent with bone metabolism in postmenopausal women. In a population-based study, cardiovascular risk factors, high-sensitivity C-reactive protein (hs-CRP), osteoprotegerin, receptor activator of nuclear factor-κB ligand, osteocalcin, CrossLaps, alkaline phosphatase, and bone mineral density (BMD) at the lumbar spine (L2-L4) and the proximal femur were measured in 382 Iranian postmenopausal women. In multiple logistic regression analysis, lower osteocalcin and CrossLaps levels were associated with a higher odds ratio (OR) of having type 2 diabetes mellitus when adjustments were made for age, hs-CRP, cardiovascular risk factors, BMD, and markers of bone metabolism [OR 5.17, CI (2.66-10.04), p < 0.0001 and OR 2.51, CI (1.37-4.61), p = 0.003, respectively]. However, lower alkaline phosphatase levels were associated with a lower OR of having type 2 diabetes mellitus [OR 0.28, CI (0.15-0.52), p < 0.0001] in regression analysis. No significant difference was found between serum osteocalcin levels of those with and without metabolic syndrome. Among the metabolic syndrome components, low osteocalcin levels had significant associations with elevated blood glucose [OR 1.89, CI (1.16-3.07), p = 0.010] and elevated waist circumference [OR 2.53, CI (1.13-5.67), p = 0.024] in multivariate analyses. In conclusion, serum osteocalcin was independently associated with glucose intolerance and abdominal obesity as the components of metabolic syndrome and type 2 diabetes mellitus in postmenopausal women. Since CrossLaps and alkaline phosphatase levels were independently associated with the presence of type 2 diabetes mellitus, the unique contribution of osteocalcin in glucose metabolism could not be concluded.
Authors:
Ali Movahed; Bagher Larijani; Iraj Nabipour; Mohammadreza Kalantarhormozi; Kamyar Asadipooya; Katayoun Vahdat; Samad Akbarzadeh; Maryam Farrokhnia; Majid Assadi; Roya Amirinejad; Afshar Bargahi; Zahra Sanjdideh
Related Documents :
11455676 - Comparison of the effects of three sulfonylureas on in vivo insulin action.
10969826 - Evidence that carotid bodies play an important role in glucoregulation in vivo.
8467106 - Glucose and fat utilization during intravenous administration of glucose and lipid emul...
22572476 - Virtualizing the assessment: a novel pragmatic paradigm to evaluate lower extremity joi...
6417336 - Hla-dr2 in two sibships with insulin-dependent diabetes mellitus.
7046346 - Effects of sulfonylurea on the secretion and disposition of insulin and c-peptide.
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-7-3
Journal Detail:
Title:  Journal of bone and mineral metabolism     Volume:  -     ISSN:  1435-5604     ISO Abbreviation:  -     Publication Date:  2012 Jul 
Date Detail:
Created Date:  2012-7-3     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9436705     Medline TA:  J Bone Miner Metab     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Affiliation:
Department of Endocrine and Metabolic Diseases, The Persian Gulf Tropical Medicine Research Centre, Bushehr University of Medical Sciences, Boostan 19 Alley, Imam Khomeini St, 7514763448, Bushehr, Islamic Republic of Iran.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Safety and effectiveness profile of raloxifene in long-term, prospective, postmarketing surveillance...
Next Document:  Low intensity ultrasound stimulates osteoblast migration at different frequencies.